Scancell (LON:SCLP) Shares Up 18.1% - Here's What Happened

Scancell Holdings plc (LON:SCLP - Get Free Report) traded up 18.1% on Monday . The stock traded as high as GBX 11 ($0.15) and last traded at GBX 10.01 ($0.13). 3,712,693 shares were traded during mid-day trading, an increase of 361% from the average session volume of 804,494 shares. The stock had previously closed at GBX 8.48 ($0.11).

Scancell Stock Performance

The company has a debt-to-equity ratio of -566.79, a current ratio of 3.42 and a quick ratio of 13.01. The company has a market capitalization of £109.27 million, a PE ratio of -16.18 and a beta of 0.35. The stock has a 50-day simple moving average of GBX 8.55 and a 200 day simple moving average of GBX 10.82.

Scancell (LON:SCLP - Get Free Report) last issued its quarterly earnings data on Thursday, January 30th. The company reported GBX (1.35) (($0.02)) EPS for the quarter. Equities analysts anticipate that Scancell Holdings plc will post -2.5361112 EPS for the current fiscal year.

About Scancell

Scancell LSE: SCLP is a clinical stage immunotherapy biotech company developing treatments for significant unmet needs in cancer. We aim to translate our innovation and creativity into increased and durable responses in patients without compromising safety, addressing hard-to-treat cancers. Scancell has developed a pipeline of ‘off-the-shelf' vaccines to induce immune responses and highly tumour specific monoclonal antibodies to redirect immune cells or drugs.